content

PHARMASEAL International, provider of clinical trials management systems has announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus...

Eli Lilly and Company announced an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop...

Covalon Technologies Ltd , an advanced medical technologies company, announces its new breakthrough antimicrobial technology formulated to kill the COVID-19 virus (or “SARS-CoV-2”) and...

U.K.-based Cobra Biologics and noted medical university the Karolinska Institute, which is based in Sweden, secured millions in emergency funding from Horizon 2020 to...

GigaGen is developing a recombinant polyclonal antibody therapy (rCIG) to treat COVID-19. First uses are envisioned as treatments for severely ill coronavirus patients and...

Johnson & Johnson is moving forward with a vaccine candidate for COVID-19. The healthcare giant said it selected a lead vaccine candidate and plans...

Two BIOCAD products, Acellbia and Herticad , received the first European registration certificate in Bosnia and Herzegovina. Registration was received with the support of...